Theratechnologies Inc. (TH.TO)
CAD 2.18
(0.46%)
CAD 2.18
(0.46%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 24.87 Million USD | -41.96% |
| 2022 | 42.85 Million USD | 17.91% |
| 2021 | 36.34 Million USD | -14.77% |
| 2020 | 42.64 Million USD | 93.14% |
| 2019 | 22.08 Million USD | 115.42% |
| 2018 | 10.24 Million USD | 849.44% |
| 2017 | -1.36 Million USD | -73.51% |
| 2016 | -788.21 Thousand USD | 93.13% |
| 2015 | -11.47 Million USD | -1794.76% |
| 2014 | -605.88 Thousand USD | 33.48% |
| 2013 | -910.82 Thousand USD | 40.16% |
| 2012 | -1.52 Million USD | 38.58% |
| 2011 | -2.47 Million USD | 90.52% |
| 2010 | -26.13 Million USD | -1720.08% |
| 2009 | -1.43 Million USD | -1241.02% |
| 2008 | -107.09 Thousand USD | 95.84% |
| 2007 | -2.57 Million USD | -18284.07% |
| 2006 | -14.01 Thousand USD | 98.49% |
| 2005 | -930.69 Thousand USD | -153.46% |
| 2004 | -367.19 Thousand USD | -799.29% |
| 2003 | -40.83 Thousand USD | 67.4% |
| 2002 | -125.24 Thousand USD | 91.93% |
| 2001 | -1.55 Million USD | -75.83% |
| 2000 | -882.58 Thousand USD | -224.91% |
| 1999 | -271.63 Thousand USD | 97.34% |
| 1998 | -10.22 Million USD | -46.92% |
| 1997 | -6.95 Million USD | -17.18% |
| 1996 | -5.93 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 22.45 Million USD | -17.79% |
| 2024 Q1 | 26.9 Million USD | 8.16% |
| 2024 Q2 | 28.15 Million USD | 4.66% |
| 2023 Q1 | 45.96 Million USD | 7.25% |
| 2023 FY | 24.87 Million USD | -41.96% |
| 2023 Q4 | 24.87 Million USD | -42.53% |
| 2023 Q3 | 43.27 Million USD | -12.96% |
| 2023 Q2 | 49.71 Million USD | 8.17% |
| 2022 Q4 | 42.85 Million USD | -0.38% |
| 2022 FY | 42.85 Million USD | 17.91% |
| 2022 Q3 | 43.01 Million USD | -2.79% |
| 2022 Q2 | 44.25 Million USD | 3.48% |
| 2022 Q1 | 42.76 Million USD | 17.66% |
| 2021 Q3 | 24 Million USD | 33.53% |
| 2021 Q2 | 17.97 Million USD | 170.49% |
| 2021 FY | 36.34 Million USD | -14.77% |
| 2021 Q4 | 36.34 Million USD | 51.44% |
| 2021 Q1 | 6.64 Million USD | -84.42% |
| 2020 Q1 | 30.62 Million USD | 38.7% |
| 2020 Q4 | 42.64 Million USD | 12.81% |
| 2020 Q3 | 37.8 Million USD | 14.25% |
| 2020 Q2 | 33.08 Million USD | 8.04% |
| 2020 FY | 42.64 Million USD | 93.14% |
| 2019 Q1 | 9.39 Million USD | -8.33% |
| 2019 FY | 22.08 Million USD | 115.42% |
| 2019 Q2 | 19.87 Million USD | 111.57% |
| 2019 Q4 | 22.08 Million USD | 14.32% |
| 2019 Q3 | 19.31 Million USD | -2.84% |
| 2018 Q4 | 10.24 Million USD | -29.91% |
| 2018 FY | 10.24 Million USD | 849.44% |
| 2018 Q3 | 14.62 Million USD | 545.21% |
| 2018 Q2 | 2.26 Million USD | 266.78% |
| 2018 Q1 | -1.35 Million USD | -117.31% |
| 2017 FY | -1.36 Million USD | -73.51% |
| 2017 Q4 | 7.85 Million USD | 2.89% |
| 2017 Q3 | 7.63 Million USD | 352.39% |
| 2017 Q1 | 8.33 Million USD | 1157.13% |
| 2017 Q2 | -3.02 Million USD | -136.28% |
| 2016 Q3 | -244.44 Thousand USD | -102.78% |
| 2016 FY | -788.21 Thousand USD | 93.13% |
| 2016 Q1 | 9.34 Million USD | 72.61% |
| 2016 Q2 | 8.78 Million USD | -5.98% |
| 2016 Q4 | -788.21 Thousand USD | -222.45% |
| 2015 FY | -11.47 Million USD | -1794.76% |
| 2015 Q3 | -11.46 Million USD | -174.51% |
| 2015 Q4 | 5.41 Million USD | 147.25% |
| 2015 Q2 | 15.38 Million USD | -3.72% |
| 2015 Q1 | 15.97 Million CAD | -3.43% |
| 2014 FY | -605.88 Thousand USD | 33.48% |
| 2014 Q4 | 16.54 Million USD | 22.82% |
| 2014 Q2 | -285.69 Thousand USD | -34.13% |
| 2014 Q1 | -213 Thousand USD | 76.61% |
| 2014 Q3 | 13.47 Million USD | 4815.43% |
| 2013 Q4 | -910.82 Thousand USD | 40.88% |
| 2013 FY | -910.82 Thousand USD | 40.16% |
| 2013 Q3 | -1.54 Million USD | -293.99% |
| 2013 Q2 | -391 Thousand USD | -406.7% |
| 2013 Q1 | -77.16 Thousand USD | 94.93% |
| 2012 Q3 | -2.56 Million USD | -153.35% |
| 2012 FY | -1.52 Million USD | 38.58% |
| 2012 Q2 | -1.01 Million USD | -1495.8% |
| 2012 Q1 | -63.36 Thousand USD | 97.44% |
| 2012 Q4 | -1.52 Million USD | 40.58% |
| 2011 Q4 | -2.47 Million USD | -380.41% |
| 2011 FY | -2.47 Million USD | 90.52% |
| 2011 Q3 | -515.85 Thousand USD | 50.11% |
| 2011 Q2 | -1.03 Million USD | -90.07% |
| 2011 Q1 | -543.96 Thousand USD | 97.92% |
| 2010 Q4 | -26.13 Million USD | -1069.52% |
| 2010 Q1 | -3.17 Million USD | -120.73% |
| 2010 FY | -26.13 Million USD | -1720.08% |
| 2010 Q2 | -3.31 Million USD | -4.55% |
| 2010 Q3 | -2.23 Million USD | 32.57% |
| 2009 Q2 | -3.51 Million USD | 35.2% |
| 2009 Q3 | -11.61 Million USD | -230.31% |
| 2009 Q4 | -1.43 Million USD | 87.64% |
| 2009 FY | -1.43 Million USD | -1241.02% |
| 2009 Q1 | -5.42 Million USD | -4968.41% |
| 2008 Q1 | -17.74 Million USD | -588.52% |
| 2008 FY | -107.09 Thousand USD | 95.84% |
| 2008 Q4 | -107.09 Thousand USD | 98.82% |
| 2008 Q3 | -9.05 Million USD | -12.75% |
| 2008 Q2 | -8.02 Million USD | 54.75% |
| 2007 Q3 | -6.19 Million USD | 47.63% |
| 2007 Q4 | -2.57 Million USD | 58.4% |
| 2007 FY | -2.57 Million USD | -18284.07% |
| 2007 Q1 | -47 Million USD | -335266.71% |
| 2007 Q2 | -11.82 Million USD | 74.84% |
| 2006 Q2 | -1.54 Million USD | -2417.14% |
| 2006 Q1 | -61.51 Thousand USD | 93.39% |
| 2006 FY | -14.01 Thousand USD | 98.49% |
| 2006 Q3 | -1.39 Million USD | 9.62% |
| 2006 Q4 | -14.01 Thousand USD | 99.0% |
| 2005 FY | -930.69 Thousand USD | -153.46% |
| 2005 Q2 | -6.05 Million USD | -34.58% |
| 2005 Q1 | -4.49 Million USD | -1125.4% |
| 2005 Q3 | -4.01 Million USD | 33.7% |
| 2005 Q4 | -930.69 Thousand USD | 76.82% |
| 2004 Q4 | -367.19 Thousand USD | -6.17% |
| 2004 Q3 | -345.85 Thousand USD | 86.87% |
| 2004 Q2 | -2.63 Million USD | 83.48% |
| 2004 Q1 | -15.94 Million USD | -38942.15% |
| 2004 FY | -367.19 Thousand USD | -799.29% |
| 2003 Q1 | -3.33 Million USD | -2560.69% |
| 2003 FY | -40.83 Thousand USD | 67.4% |
| 2003 Q4 | -40.83 Thousand USD | 97.85% |
| 2003 Q3 | -1.9 Million USD | 56.36% |
| 2003 Q2 | -4.35 Million USD | -30.75% |
| 2002 Q1 | -13.06 Million CAD | -741.73% |
| 2002 Q4 | -125.24 Thousand USD | 98.69% |
| 2002 Q3 | -9.56 Million CAD | -34.66% |
| 2002 Q2 | -7.1 Million CAD | 45.6% |
| 2002 FY | -125.24 Thousand USD | 91.93% |
| 2001 Q3 | -20.51 Million CAD | -187.96% |
| 2001 Q1 | -1.17 Million CAD | -33.02% |
| 2001 FY | -1.55 Million USD | -75.83% |
| 2001 Q2 | -7.12 Million CAD | -506.89% |
| 2001 Q4 | -1.55 Million CAD | 92.44% |
| 2000 Q1 | -1.92 Million CAD | -610.36% |
| 2000 Q3 | -11.75 Million USD | 3.2% |
| 2000 FY | -882.58 Thousand USD | -224.91% |
| 2000 Q4 | -882.58 Thousand CAD | 92.49% |
| 2000 Q2 | -12.14 Million USD | -529.49% |
| 1999 Q1 | -9.28 Million USD | 9.2% |
| 1999 Q2 | -13.08 Million USD | -41.04% |
| 1999 FY | -271.63 Thousand USD | 97.34% |
| 1999 Q4 | -271.63 Thousand USD | 98.3% |
| 1999 Q3 | -15.99 Million USD | -22.17% |
| 1998 Q3 | -10.12 Million USD | 9.53% |
| 1998 Q2 | -11.19 Million USD | -96.62% |
| 1998 Q1 | -5.69 Million USD | 18.19% |
| 1998 Q4 | -10.22 Million USD | -0.96% |
| 1998 FY | -10.22 Million USD | -46.92% |
| 1997 Q1 | -9.64 Million USD | 0.0% |
| 1997 Q3 | -8.35 Million USD | -4.63% |
| 1997 Q4 | -6.95 Million USD | 16.69% |
| 1997 FY | -6.95 Million USD | -17.18% |
| 1997 Q2 | -7.98 Million USD | 17.25% |
| 1996 FY | -5.93 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aurora Cannabis Inc. | -8.64 Million CAD | 387.593% |
| Avicanna Inc. | 1.32 Million CAD | -1775.36% |
| Avant Brands Inc. | 17.93 Million CAD | -38.712% |
| Cardiol Therapeutics Inc. | -34.77 Million CAD | 171.523% |
| Crescita Therapeutics Inc. | -8.13 Million CAD | 405.879% |
| Knight Therapeutics Inc. | 10.33 Million CAD | -140.765% |
| MediPharm Labs Corp. | -15.68 Million CAD | 258.555% |
| OrganiGram Holdings Inc. | -33.7 Million CAD | 173.781% |
| Canopy Growth Corporation | 512.87 Million CAD | 95.151% |
| Willow Biosciences Inc. | -989 Thousand CAD | 2614.762% |
| Auxly Cannabis Group Inc. | 142.88 Million CAD | 82.593% |